J. B. Chemicals & Pharmaceuticals Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of J. B. Chemicals & Pharmaceuticals Limited generated cash of $8,006,117,000, which is more than the previous year. Cash used in financing activities reached the amount of -$3,740,799,000 last year. Net change in cash is therefore $112,807,000.
Cash Flow
| 2010 | 1.21B | -294.63M | -584.93M |
|---|---|---|---|
| 2011 | 1.33B | -894.56M | 46.57M |
| 2012 | 8.79B | -2.60B | -5.26B |
| 2016 | 1.39B | -320.32M | -1.19B |
| 2018 | 1.23B | -208.08M | -595.23M |
| 2020 | 2.75B | 243.02M | -3.06B |
| 2021 | 3.14B | -2.30B | -874.22M |
| 2023 | 6.25B | -9.61B | 3.56B |
| 2024 | 8.00B | -4.03B | -3.74B |
JBCHEPHARM.NS Cash Flow Statement (2010 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 769.34M | 565.4M | 257.51M | 321.41M | -214.73M | 251.87M | 1.26B | 778.61M | 438.45M |
Operating activities | |||||||||
Net income | 5.52B | 5.55B | 5.96B | 3.48B | 1.93B | 2.08B | 6.77B | 1.39B | 1.18B |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 1.38B | 1.14B | 686.65M | 663.22M | 569.73M | 412.36M | 224.24M | 227.87M | 215.68M |
Stock-based compensation expense | 419.66M | 693.7M | 0 | 0 | 0 | 0 | 0 | 0 | -42K |
| Deferred income tax benefit | 419.66M | 693.7M | 0 | 0 | 0 | 0 | 0 | 0 | -42K |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | -716M | -417.46M | -705.98M | -114.95M | -528.75M | -316.97M | 0 | 0 | 0 |
Inventories | -720.3M | -205.2M | -700.85M | -309.12M | -135.62M | -179.53M | 106.37M | -281.98M | -26.97M |
Accounts payable | 1.38B | 323.49M | 464.75M | 521.06M | 193.63M | 430.56M | 0 | 0 | 0 |
Cash generated by operating activities | 8.00B | 6.25B | 3.14B | 2.75B | 1.23B | 1.39B | 8.79B | 1.33B | 1.21B |
Investing activities | |||||||||
Purchases Of Investments | -8.68B | -7.56B | -5.41B | -3.82B | -4.20B | -1.99B | -17.17B | -4.57B | -207.60M |
Investments In Property Plant And Equipment | -1.26B | -7.64B | -477.73M | -729.67M | -365.56M | -1.99B | -801.03M | -343.58M | -126.31M |
Acquisitions Net | 0 | 1.99B | -85M | 65.54M | 97.43M | -522.99M | 0 | 16K | 0 |
Cash generated by investing activities | -4.03B | -9.61B | -2.30B | 243.02M | -208.08M | -320.32M | -2.60B | -894.56M | -294.63M |
Financing activities | |||||||||
Common Stock Issued | 199.91M | 84.82M | 0 | 0 | 0 | 1.11M | 15.78M | 14.89M | 0 |
Payments for dividends | -1.56B | -1.27B | -732.40M | -1.41B | -103.35M | -1.87B | -4.12B | -196.54M | -98.36M |
Repurchases of common stock | 0 | 0 | 0 | -1.60B | -500M | 0 | 0 | 0 | 0 |
Repayments of term debt | -1.91B | 5.23B | -3.22M | 63.14M | 39.5M | 886.45M | -1.01B | -248.62M | -486.57M |
Cash used in financing activities | -3.74B | 3.56B | -874.22M | -3.06B | -595.23M | -1.19B | -5.26B | 46.57M | -584.93M |
Net Change In Cash | 112.80M | 203.9M | -32.78M | -63.89M | 427.15M | -102.30M | 926.46M | 490.23M | 340.16M |
Cash at end of period | 882.15M | 769.3M | 224.73M | 257.51M | 212.42M | 149.56M | 2.19B | 1.26B | 778.61M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |